secwatch.observer — SEC 8-K summary ====================================== Issuer: ASP Isotopes Inc. (ASPI) CIK: 0001921865 Form: 8-K Filed at: 2026-10-02T10:01:02+00:00 Accession: 0001477932-26-005971 Event type: m_and_a Sentiment: neutral Materiality: 0.45 Item codes: 7.01 LLM model: deepseek-v4.1-flash:cloud@v2 ASP Isotopes: ENDRA files Form S-4 for Renergen/Noble Africa merger; combined company targets Nasdaq listing -------------------------------------------------------------------------------- - Merger structure: ENDRA's Kruger Merger Sub LLC will merge into ASPI's wholly-owned Noble Africa LLC, which survives as a direct wholly-owned subsidiary of ENDRA Life Sciences. - Merger Agreement dated June 25, 2026 among ENDRA, Noble Africa LLC, Renergen Limited, ASP Isotopes Inc. and Kruger Merger Sub LLC. - ENDRA filed the Form S-4 Registration Statement on October 2, 2026 containing information about Renergen; amendments and further SEC filings are expected. - Expected debt funding comes from the U.S. International Development Finance Corporation or Standard Bank SA; Renergen's Virginia Gas Project and its funding timeline are cited. - Closing conditions include ENDRA stockholder approval and completion of the proposed financings; the combined company is expected to list on Nasdaq after closing. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000147793226005971/0001477932-26-005971-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1921865/000147793226005971/aspi_8k.htm HTML page: https://secwatch.observer/filing/0001477932-26-005971 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer